Stonepine Capital Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Stonepine Capital Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-98,064	Closed	-$458K	–	27
2016 Q3	$458K	Sell	98,064 -185,242	-65%	-$865K	0.37%	16
2016 Q2	$1.12M	Sell	283,306 -224,493	-44%	-$839K	1.14%	19
2016 Q1	$1.57M	Hold	507,799	–	–	1.86%	12
2015 Q4	$2.32M	Buy	+507,799	New	+$2.41M	2.72%	11

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Stonepine Capital Management's DSCI Position: Q4 2016 in Review

Stonepine Capital Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2016, closing a stake of 98,064 shares — an estimated $458K sold.

Stonepine Capital Management first reported a position in DSCI in Q4 2015 and held it in 4 quarters. The position peaked at $2.32M in Q4 2015. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

Stonepine Capital Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2016 after selling out during the quarter.
Stonepine Capital Management sold 98,064 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2016, an estimated $458K.
Stonepine Capital Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2015 and held it in 4 quarters.
Stonepine Capital Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $2.32M in Q4 2015.
52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on Stonepine Capital Management's 13F filing for Q4 2016, filed 10 Feb 2017.